Inhibition of pancreatic adenocarcinoma cellular invasiveness by blebbistatin: a novel myosin II inhibitor
- 18 December 2003
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 313 (4), 992-997
- https://doi.org/10.1016/j.bbrc.2003.12.031
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II InhibitorScience, 2003
- Myosin Light Chain Kinase Inhibitors Can Block Invasion and Adhesion of Human Pancreatic Cancer Cell LinesPancreas, 2002
- Signal transduction by G‐proteins, Rho‐kinase and protein phosphatase to smooth muscle and non‐muscle myosin IIThe Journal of Physiology, 2000
- Fibronectin and integrins in invasion and metastasisCancer and Metastasis Reviews, 1995
- The Role of Actin Polymerization in Cell MotilityAnnual Review of Physiology, 1991
- Substance P contracts bovine tracheal smooth muscle via activation of myosin light chain kinaseAmerican Journal of Physiology-Cell Physiology, 1990
- Binding and Biological Effects of Tumor Necrosis Factor and Gamma Interferon in Human Pancreatic Carcinoma CellsPancreas, 1990
- Actin filaments mediate Dictyostelium myosin assembly in vitro.Proceedings of the National Academy of Sciences of the United States of America, 1989
- Active site trapping of nucleotide by smooth and non-muscle myosinsJournal of Molecular Biology, 1988
- Calcium control of actin-myosin based contraction in triton models of mouse 3T3 fibroblasts is mediated by the myosin light chain kinase (MLCK)-calmodulin complexExperimental Cell Research, 1983